Evaluation of patient outcomes in an area where prescribing of anticholinergic antidepressants was influenced by academic detailing
Publication date
2002-08
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
OBJECTIVE: To evaluate, on a patient level, the effect of a "physician-level intervention" that successfully reduced the incidence of anticholinergic antidepressant prescribing. DESIGN: Cross-sectional surveys with questionnaires sent before and after intervention. SETTING: Additional study in an RCT to reduce the prescribing of highly anticholinergic antidepressants in the elderly in the South Holland Islands. PARTICIPANTS: Elderly patients (age 60-95 years) who used antidepressants in 1995 and 1996 in our research area according to a health insurance prescription database. MAIN OUTCOME MEASURES: Prevalence of adverse events related to antidepressant use, severity of depression and quality of life were compared in users living in the intervention and control areas. RESULTS: Prior to our intervention we sent 2,359 questionnaires of which we could use 827 (35%) for analysis. At baseline, there were no statistically significant differences between the intervention and control areas. After the intervention 3,375 questionnaires were sent, of which 939 (28%) could be used. The occurrence of "dry mouth" and "coughing" and the "amount of pain" were lower in the intervention area compared to the control area (p < 0.05). CONCLUSION: We found no indications that adverse events, severity of depression or quality of life were changed in an unfavourable direction, when comparing patients inside and outside the intervention area.
Keywords
Aged, Aged, 80 and over, Antidepressive Agents, Cholinergic Antagonists, Cross-Sectional Studies, Data Collection, Drug Prescriptions, Drug Utilization, Female, Humans, Male, Middle Aged, Netherlands, Questionnaires, Treatment Outcome
Citation
van Eijk, M E C, Belitser, S V, Porsius, A J & de Boer, A 2002, 'Evaluation of patient outcomes in an area where prescribing of anticholinergic antidepressants was influenced by academic detailing', Pharmacy World & Science, vol. 24, no. 4, pp. 144-148.